Insider Trading & Ownership - WEAVER GREGORY L

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for WEAVER GREGORY L
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-15
Sale
2023-11-17
4:01 pm
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Former EVP, CFO, & Director
50,000$0.65$32,50055
(Direct)
View
2023-06-20
Purchase
2023-06-20
8:15 pm
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
EVP & CFO
50,000$0.97$48,50050,055
(Direct)
View
2021-07-02
Sale
2021-07-07
4:29 pm
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
107,497$5.58$599,8330
(Direct)
View
2021-06-22
Purchase
2021-06-24
4:15 pm
ATAI Life Sciences N.V.ATAIWEAVER GREGORY L
Chief Financial Officer
4,666$15$69,9904,666
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-11
Option Award
2024-11-12
4:50 pm
N/A
2034-11-11
Altimmune Inc.ALTWEAVER GREGORY L
Chief Financial Officer
300,000$0300,000
(Direct)
View
2023-06-01
Option Award
2023-06-05
09:00 am
N/A
2033-06-01
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
EVP & CFO
2,600,000$02,600,000
(Direct)
View
2023-05-04
Option Award
2023-05-05
7:36 pm
N/A
2033-05-04
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
125,000$0125,000
(Direct)
View
2022-05-13
Option Award
2022-05-16
6:19 pm
N/A
2032-05-13
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
50,000$050,000
(Direct)
View
2022-03-02
Option Award
2022-03-04
3:56 pm
N/A
2032-03-01
ATAI Life Sciences N.V.ATAIWEAVER GREGORY L
Chief Financial Officer
228,000$0228,000
(Direct)
View
2021-07-02
Exercise
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
70,000$1.70
(Direct)
View
2021-07-02
Exercise
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
164,581$00
(Direct)
View
2021-07-02
Exercise
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
4,581$5.640
(Direct)
View
2021-07-02
Exercise
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
45,000$2.520
(Direct)
View
2021-07-02
Exercise
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
45,000$2.380
(Direct)
View
2021-07-02
Tax Withholding
2021-07-07
4:29 pm
N/A
N/A
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
57,084$6.40
(Direct)
View
2021-06-17
Option Award
2021-06-22
4:20 pm
N/A
2031-06-17
ATAI Life Sciences N.V.ATAIWEAVER GREGORY L
Chief Financial Officer
67,726$067,726
(Direct)
View

Ownership
2021-06-17
6:08 pm
N/A
2025-08-20
ATAI Life Sciences B.V.ATAIWEAVER GREGORY L
Chief Financial Officer
0$0880,000
(Direct)
View
2021-05-14
Option Award
2021-05-18
4:16 pm
N/A
2031-05-14
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
50,000$050,000
(Direct)
View
2020-05-15
Option Award
2020-05-19
2:06 pm
N/A
2030-05-15
ATOSSA THERAPEUTICS INC.ATOSWEAVER GREGORY L
Director
70,000$070,000
(Direct)
View
2020-03-15
Exercise
2020-03-16
4:10 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
FORMER CHIEF FINANCIAL OFFICER
3,750$010,431
(Direct)
View
2020-03-15
Tax Withholding
2020-03-16
4:10 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
FORMER CHIEF FINANCIAL OFFICER
1,086$2.8510,431
(Direct)
View
2020-01-30
Tax Withholding(A)
2020-03-04
2:30 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
CHIEF FINANCIAL OFFICER
1,733$3.9122,767
(Direct)
View
2020-01-30
Exercise(A)
2020-03-04
2:30 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
CHIEF FINANCIAL OFFICER
5,000$022,767
(Direct)
View
2020-01-30
Tax Withholding
2020-01-31
5:26 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
CHIEF FINANCIAL OFFICER
1,733$3.9122,767
(Direct)
View
2020-01-30
Exercise
2020-01-31
5:26 pm
N/A
N/A
Eloxx Pharmaceuticals Inc.ELOXWEAVER GREGORY L
CHIEF FINANCIAL OFFICER
5,000$022,767
(Direct)
View
(A) Indicate amendment filing.